A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia
Version 2 2024-06-13, 17:46
Version 1 2022-06-10, 09:14
journal contribution
posted on 2024-06-13, 17:46 authored by CP Gilfillan, BJS Strauss, CP Rodda, DK Bowden, AM Kean, M Obaid, BA CrawfordA randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia
